11:54 GMT15 July 2020
Listen Live
    Europe
    Get short URL
    233
    Subscribe

    MOSCOW (Sputnik) - The coronavirus vaccine developed by Oxford University and pharmaceutical giant AstraZeneca could have only a 50-percent chance of success, Professor Adrian Hill told The Telegraph newspaper.

    "It's a race against the virus disappearing, and against time. At the moment, there's a 50% chance that we get no result at all", Adrian Hill, director of Oxford's Jenner Institute, said on Saturday.

    According to Hill, an upcoming trial of the experimental vaccine, involving 10,000 volunteers, could return "no result" due to low transmission of COVID-19 in the British community.

    Earlier, Hill’s team spoke of an 80-percent success of the vaccine, which was expected to be ready by September.

    Early-stage human trials of the vaccine started on 23 April. AstraZeneca received $1.2 billion from the US government to produce 400 million doses of the vaccine. The results of the first-stage clinical trials are expected in June.

    Meanwhile, pre-clinical trials of a vaccine against the coronavirus conducted by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology of the Russian Health Ministry are showing good results, and human trials are expected to start by 15 June, according to Director Alexander Gintsburg.

    Related:

    Russia's Gamalei Institute Expects to Launch Human Trials for COVID-19 Vaccine by 15 June
    COVID-19 Vaccine Trial Produced ‘Immediate’ Immune Response in Mice - Chinese Researchers
    US Top Health Expert Fauci Explains Risks Behind Development of COVID-19 Vaccine
    Tags:
    Oxford University, vaccine, COVID-19
    Community standardsDiscussion